×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by EBERT CHARLES D

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ACTActavis plcEBERT CHARLES DSVP, BRANDS R&DNov 06, 2013Sale$158.7510,8771,726,7247,611Nov 08, 2013, 04:08 PM
ACTActavis, Inc.EBERT CHARLES DSr. VP, Research & DevelopmentSep 30, 2013Option Exercise$144.0013,6941,971,93618,488Oct 02, 2013, 08:59 PM
ACTActavis, Inc.EBERT CHARLES DSr. VP, Research & DevelopmentAug 05, 2013Sale$136.258,2441,123,24519,970Aug 13, 2013, 06:13 PM
ACTActavis, Inc.EBERT CHARLES DSr. VP, Research & DevelopmentAug 05, 2013Option Exercise$136.258,2441,123,24519,970Aug 06, 2013, 04:00 PM
ACTActavis, Inc.EBERT CHARLES DSr. VP, Research & DevelopmentMar 05, 2013Option Exercise$86.461,331115,07823,834Mar 07, 2013, 02:55 PM
ACTActavis, Inc.EBERT CHARLES DSr. VP, Research & DevelopmentMar 02, 2013Option Exercise$85.541,761150,63625,165Mar 05, 2013, 07:19 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentMar 14, 2012Option Exercise$59.211,26574,90126,926Mar 16, 2012, 02:17 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentFeb 29, 2012Option Exercise$25.641,00025,64027,264Mar 01, 2012, 04:32 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentFeb 29, 2012Sale$58.804,981292,89826,264Mar 01, 2012, 04:32 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentFeb 24, 2012Option Exercise$58.171,45884,81226,264Feb 28, 2012, 12:20 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentJun 01, 2011Sale$64.452,635169,82627,722Jun 01, 2011, 07:28 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentMar 11, 2011Option Exercise$56.8961635,04430,357Mar 15, 2011, 04:11 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentMar 05, 2011Option Exercise$56.791,29573,54330,973Mar 08, 2011, 04:29 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentMar 03, 2011Option Exercise$48.857,500366,37539,768Mar 04, 2011, 04:29 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentMar 03, 2011Sale$56.367,500422,70032,268Mar 04, 2011, 04:29 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentDec 06, 2010Sale$51.003,639185,58925,149Dec 07, 2010, 04:25 PM
WPIWATSON PHARMACEUTICALS INCEBERT CHARLES DSr. VP, Research & DevelopmentSep 01, 2010Option Exercise$44.152169,53628,788Sep 02, 2010, 06:21 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe